NASDAQ:NLTX
Delisted

Neoleukin Therapeutics Stock Signals

etoro logo Buy NLTX
*Your capital is at risk
$3.49
+0 (+0%)
At Close: Mar 15, 2024

Latest Data & Signals Issued

Below are some of the latest signals issued for Neoleukin Therapeutics Inc

General

Signal Type Signal Value Data
Score 0.000 62 days ( -1.45 %
Last Price $3.49 0 %
Performance History
7 Days
$3.49 $3.49
0%
30 Days
$3.49 $3.49
0%
12 Mos
$0.699 $3.49
399.50%

9/18

Active Buy Signals

Specific Signals

Short Term
Net score: 35.81
Signal Type Signal Value Importance Data
High / Low N/A Very Low $3.49 - $3.49
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Mar 14, 2024 - 2 days
RSI Short Pivot Signal Buy Very Low Dec 28, 2023 - 54 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Buy Medium Dec 20, 2023 - 59 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 79.92
Signal Type Signal Value Importance Data
Trend - 12 mos 219.12 % Very High Width: 124.57 %
Pred. range - 12 mos $8.35 - $18.75 High 139.26 % - 437.31 %
Short MA 12 mos Buy Very High Dec 14, 2023 - 63 days
Long MA 12 mos Buy Very High Feb 28, 2024 - 13 days
Short/Long MA 12 mos Buy Very High Feb 28, 2024 - 13 days
Pivot Long Sell Low Mar 14, 2024 - 2 days
RSI Long Pivot Signal Buy Low Jan 09, 2024 - 47 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT NEOLEUKIN THERAPEUTICS INC
Neoleukin Therapeutics
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aqui...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE